Growth Metrics

Canton Strategic Holdings (CNTN) Non-cash Items (2021 - 2026)

Canton Strategic Holdings posted quarterly Non-cash Items of $656163.0 for Q1 2026, up 215.29% year-on-year from $208111.0 in Q1 2025, and little changed on a QoQ basis from $657042.0 in Q4 2025.

Canton Strategic Holdings (CNTN) has 5 years of Non-cash Items data on file, last reported at $656163.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non-cash Items rose 215.29% year-over-year to $656163.0; the trailing twelve-month figure through Mar 2026 stood at $656163.0 (up 215.29% YoY), and the FY2025 full-year result was $657042.0, changed N/A from the prior year.
  • Non-cash Items for Q1 2026 stood at $656163.0, roughly flat from $657042.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $823597.0 in Q1 2022 and bottomed at $5323.0 in Q2 2024.
  • The 4-year median for Non-cash Items is $423037.5 (2025), against an average of $402362.9.
  • The widest annual swing landed in 2025, when Non-cash Items surged 4390.57%; it then soared 215.29% in 2026.
  • A 4-year view of Non-cash Items shows it stood at $823597.0 in 2022, then slumped by 97.26% to $22592.0 in 2024, then jumped by 2808.29% to $657042.0 in 2025, then retreated by 0.13% to $656163.0 in 2026.
  • The last three Non-cash Items figures came in at $656163.0 (Q1 2026), $657042.0 (Q4 2025), and $607042.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 656,163.00
Mar 31, 2026 656,163.00
Dec 31, 2025 657,042.00
Dec 31, 2025 657,042.00
Sep 30, 2025 607,042.00
Sep 30, 2025 607,042.00
Jun 30, 2025 239,033.00
Jun 30, 2025 239,033.00
Mar 31, 2025 208,111.00
Mar 31, 2025 208,111.00
Sep 30, 2024 22,592.00
Sep 30, 2024 22,592.00
Jun 30, 2024 5,323.00
Jun 30, 2024 5,323.00
Mar 31, 2022 823,597.00
Mar 31, 2022 823,597.00
Dec 31, 2021 580,642.00
Dec 31, 2021 580,642.00